INS and type 2 diabetes mellitus: The switch to Icodec vs. Glargine U100 in T2D patients who failed to achieve adequate glucose control with other basal insulins was slightly better in terms of the glucose control attained in 15 weeks, especially when a loading dose of Icodec (+100%) was administered at the switching time [33].